Positive

Pashtoon Kasi: Nice birthday present! Keeping this one close to my heart

Photo from Pashtoon Kasi/LinkedIn

May 27, 2024, 11:56

Pashtoon Kasi: Nice birthday present! Keeping this one close to my heart

Pashtoon Kasi shared a post by OncoDaily on LinkedIn:

“Oh wow! Nice birthday present! Keeping this one close to my heart.

Yvonne Award for ‘Challenging the Status Quo!’

To those who dare to think differently and implement groundbreaking approaches that redefine cancer care.

Here’s to challenging the status quo.”

Quoting OncoDaily’s post:

“Congratulations to Pashtoon Kasi and Erica Tsang for winning the Yvonne Award 2024 in the ‘Challenging the Status Quo’ category!

Your remarkable efforts and dedication have significantly transformed the field of oncology.

The award will be handed out on May 31st at 8:30 pm in Chicago, IL, USA, during the OncoDaily Party.

P.S. If you haven’t received your party invitation yet, please check your mailbox first. If it’s not there, don’t forget to write to us.”

Proceed to video attached to post.

Source: Pashtoon Kasi/LinkedIn and OncoDaily/LinkedIn

Dr. Pashtoon Kasi is a medical oncologist and researcher at Weill Cornell Medicine and NewYork-Presbyterian Hospital. Within his roles at Weill Cornell Medicine, he holds the positions of Director for Colorectal Cancer Research and Precision Medicine Director for Liquid Biopsy Research at the Englander Institute of Precision Medicine.

Previously, Dr. Kasi served as an Associate Professor of Medicine in the Division of Hematology and Oncology at the University of Iowa, following positions as an Assistant Professor of Medicine and Oncology at both the University of Iowa and Mayo Clinic.

His research primarily focuses on “liquid biopsies,” particularly circulating tumor DNA (ctDNA) and circulating tumor cells (CTCs). Dr. Kasi is also recognized as an author and editor of several significant books, including “Research: What, Why, and How: A Treatise from Researchers to Researchers” and “Impact of Circulating Tumor DNA (ctDNA) in Patients with Gastrointestinal Malignancies.” His scholarly contributions extend to over 100 publications in esteemed peer-reviewed journals.